Xenon Pharmaceuticals saw the highest growth of 0.99% in patent filings and 1.32% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and grants by 1.32%. GlobalData’s DataBook provides a comprehensive analysis of Xenon Pharmaceuticals‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Xenon Pharmaceuticals has been focused on protecting inventions in Israel(IL) with four publications in Q2 2024
The Israel(IL) Patent Office dominates the patent filings and grants with nearly 50% filings and 25% grants. The Israel(IL), Australia(AU), South Korea(KR), and Spain(ES) patent Office are among the top ten patent offices where Xenon Pharmaceuticals is filings its patents. Among the top granted patent authorities, Xenon Pharmaceuticals has 50% of its grants in Spain(ES), 25% in Israel(IL) and 25% in United States(US).
In terms of grant share, Xenon Pharmaceuticals stands in ninth position among its competitors. and secured the top positions according to recent patent publication data.
Patents related to rare diseases lead Xenon Pharmaceuticals's portfolio
Xenon Pharmaceuticals has the highest number of patents in rare diseases. For rare diseases no patents were filed and 100% of patents were granted in Q2 2024.
Epilepsy related patents lead Xenon Pharmaceuticals portfolio followed by stroke, and depression
Xenon Pharmaceuticals has highest number of patents in epilepsy followed by stroke, depression, human immunodeficiency virus (hiv) infections (aids), and lupus erythematosus. For epilepsy, nearly 100% of patents were filed and 14% of patents were granted in Q2 2024.
For comprehensive analysis of Xenon Pharmaceuticals's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
